Literature DB >> 6295145

Aplastic anemia and non-A, non-B hepatitis.

J B Zeldis, J L Dienstag, R P Gale.   

Abstract

Severe aplastic anemia is a rare but important complication of hepatitis. The agent(s) responsible for the hepatitis in these cases have not been well defined. Sixteen patient with hepatitis-associated aplastic anemia were studied for evidence of recent infection with hepatitis A virus, hepatitis B virus, cytomegalovirus, Epstein-Barr virus, and Toxoplasma. Results were compared with data from 10 randomly selected patients with aplastic anemia unassociated with hepatitis. Of the 16 patients, recent acute hepatitis A infection could be excluded in at least 14 patients. Hepatitis B surface antigen (HBsAg) was present in only one patient. A diagnosis of recent hepatitis B infection could not be excluded with confidence in two others. Tests for cytomegalovirus, Epstein-Barr virus, and Toxoplasma gave negative results. No patient with aplasia unassociated with hepatitis had evidence of recent hepatitis A infection, and the frequency of hepatitis B antibodies in this group was indistinguishable from that in patients with hepatitis. These data indicate that most cases of hepatitis that preceded aplastic anemia were not caused by hepatitis A virus or hepatitis B virus; non-A, non-B agents were probably involved in at least 13 of the 16 cases studied.

Entities:  

Mesh:

Year:  1983        PMID: 6295145     DOI: 10.1016/0002-9343(83)91119-1

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  13 in total

1.  Myelopoiesis in vitro is suppressed by hepatitis A virus.

Authors:  F W Busch; A Kunst; B Flehmig; H G Mergenthaler; G Pawelec; A Vallbracht
Journal:  Ann Hematol       Date:  1992-06       Impact factor: 3.673

Review 2.  Non-A, non-B hepatitis.

Authors:  T N Dewar
Journal:  West J Med       Date:  1990-08

3.  Liver transplantation for fulminant hepatic failure.

Authors:  S Iwatsuki; A C Stieber; J W Marsh; A G Tzakis; S Todo; B Koneru; L Makowka; R D Gordon; T E Starzl
Journal:  Transplant Proc       Date:  1989-02       Impact factor: 1.066

4.  In vitro hepatitis B virus infection of human bone marrow cells.

Authors:  J B Zeldis; H Mugishima; H N Steinberg; E Nir; R P Gale
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

Review 5.  Mode of hepatitis C virus infection, epidemiology, and chronicity rate in the general population and risk groups.

Authors:  H L Tillmann; M P Manns
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

6.  Hyoplastic [correction of Hyperplastic] anaemia and parvovirus infection.

Authors:  D P Bentley
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-04

Review 7.  Substance abuse, HIV-1 and hepatitis.

Authors:  Nirzari Parikh; Michael R Nonnemacher; Vanessa Pirrone; Timothy Block; Anand Mehta; Brian Wigdahl
Journal:  Curr HIV Res       Date:  2012-10       Impact factor: 1.581

8.  Severe aplastic anemia associated with seronegative community-acquired hepatitis C virus infection.

Authors:  A Gruber; L Grillner; H Norder; L Magnius; M Björkholm
Journal:  Ann Hematol       Date:  1993-03       Impact factor: 3.673

9.  Hepatitis B virus replication within the human spleen.

Authors:  A M Di Bisceglie; J H Hoofnagle
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

10.  Aplastic anemia complicating orthotopic liver transplantation for non-A, non-B hepatitis.

Authors:  A G Tzakis; M Arditi; P F Whitington; K Yanaga; C Esquivel; W A Andrews; L Makowka; J Malatak; D K Freese; P G Stock
Journal:  N Engl J Med       Date:  1988-08-18       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.